Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Clinical Trial of Mifepristone for Bipolar Depression [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 clinical trial evaluating mifepristone for bipolar depression sponsored by the National Institute of Mental Health, which has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mifepristone (mifepristone)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED